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INTRODUCTION
Neonatal seizures are one of the most common and distinctive
clinical manifestations of dysfunction of neurological system. Neonatal
seizures represent non-specific responses of the immature nervous system
to varied insults and result in considerable neonatal mortality and long-
term morbidity including motor and cognitive disabilities in the
childhood (1,2). Although prompt diagnostic and therapeutic interventions
are needed, multiple challenges impede the physician’s evaluation and
management of the newborn with suspected seizures. These neonatal
seizures are often under-recognized, and difficult to treat.Hence it is
critical to recognize seizures early and initiate immediate therapy.
Recognition of etiology is often helpful in prognosis and treatment.
Studies suggest that neonatal seizures and their etiology have a significant
impact on the developing brain; however, in clinical practice at neonatal
intensive care units (ICU), in developing countries where synchronised
video-EEG monitoring is practically non-existent, clinical observation
becomes the key to the diagnosis (3).
Hence we undertook this study in our centre where continuous
video-EEG monitoring is not possible to identify neonatal seizures,
thereby applying clinical criteria and also to find out the biochemical
abnormalities associated with these clinical seizures.
AIMS AND OBJECTIVES
1. To study the incidence of biochemical abnormalities associated
with neonatal seizures.
2. To study the clinical presentation, time of onset and its relation to
the neonatal seizures in newborn unit, department of paediatrics,
Government kilpauk medical college hospital, Chennai.
NEED FOR THE STUDY
? Biochemical abnormalities are one of the most common causes of
neonatal seizures which may be primary or associated with other causes
for which specific treatment is available. Early identification and
correction of these biochemical disturbances are necessary to control
seizures and to prevent permanent brain damage, as antiepileptic drugs
alone are generally ineffective if the electrolyte disorder persists.
? The prognosis and the outcome of the neonates also depends upon
the etiology of seizures. Since seizures due to transient metabolic
disturbances if identified and treated early, it is associated with good
prognosis and further we can prevent long term sequelae like cognitive
deficits ranging from learning disability to developmental delay, cerebral
palsy and mental retardation, as well as later life epilepsy as reported by
various studies.
? To avoid the unwanted long term use of anticonvulsants and to
prevent the side effects associated with their use.
 Hence we undertook the study in our neonatal unit to find out the
incidence of biochemical abnormalities associated with neonatal seizures.
                              REVIEW OF LITERATURE
“A seizure is defined as paroxysmal electrical discharge from brain
which may manifest as motor, sensory, behavioural or autonomic
dysfunctions”[4].
It results from excessive synchronous electrical discharge, due to
depolarization of neurons produced by the inward movement of sodium
ions .Moreover the threshold for seizure generation is lower in the
developing brain than in the mature brain.[5].
INCIDENCE
Seizures are more common in the neonatal period than in any other
stage of life affecting approximately 1% of all neonates(6),even more
common in preterm babies than term babies, suggesting the immaturity of
brain functions and improper myelination. Incidence of seizures ranges
from0.5-3 per1000 term infants to 1-13% in preterm infants with very
low birth weight(7). However, the reported incidence of neonatal seizures
varies widely across studies.
Global data
The variability in incidence is due to varied reasons that is
primarily the result of inconsistent diagnostic criteria, subtle clinical
manifestations of neonatal seizures, electroclinical dissociation and their
potential confusion with non epileptic neonatal behaviours.
According to Mikati  et  al, incidence of seizures ranges from
2.8/1000 in term appropriate for gestational age to57.5/1000 in preterm
very low birth weight babies(VLBW)(4) whereas Rennie et al reported a
range from 0.1–0.5% in term neonates and 10–22.7% in preterm neonates
in his studies(8).
Indian data
The National Neonatal Perinatal Database (NNPD; 2002-03),
which is the largest database collection in India collected data from 18
tertiary care units across the country, has reported an incidence of 10.3
per 1000 live-births.The incidence was found to increase with decreasing
gestation and birth weight - for example, preterm infants had almost twice
the incidence when compared to term neonates (20.8 vs. 8.4 per 1000
live-births) while very low birth weight infants had more than 4-fold
higher incidence (36.1 per 1000 live-births)(9).
Ajay kumar et al in his study on clinico-etiological and EEG
profile of neonatal seizures has found out the overall incidence to be
11.7/1000 live births with majority being in preterm babies (6.14%)
compared to term babies (0.69%)(10)
According to a study conducted by Yadav et al(11)in UttarPradesh,
cumulative frequency of neonatal convulsion was 5.52% where as similar
study by Aziz et  al has found out the cumulative frequency being 3.9%
.(12)
However the incidence of neonatal seizures is more common in
preterm than term babies and much more common in very low birth
weight babies which was supported by various studies.
In  a  study  by Ronen  et  al  and  Gabriel  et  al(72), they observed
Clinical neonatal seizures occur 6 times more often in preterm infants
than in term infant and Scher  and Aso  Et  Al (73)in their study also has
found the relative incidence is higher in premature infants less than 30
weeks gestation, occurring in 3.9% of these neonates compared with
1.5% of older infants.
In a recent study by Kohlet Et Al(74,75), seizures can occur in 5.6%
of very low birthweight infants , with lower gestational age, male gender,
and major systemic and neurological injury such as intraventricular
hemorrhage or periventricular leukomalacia being independent predictors
of neonatal seizures.
CLASSIFICATION
A seizure is a sudden, paroxysmal depolarisation of a group of
neurons that results in a transient alteration in neurological state. This
may involve abnormal motor,sensory, or autonomic activity, with or
withouta change in conscious level(13).A seizure may arise from varying
foci at different times. Not all clinical seizures are correlated with EEG
changes and not all seizures shown on EEG recordings are clinically
apparent. Based on the EEG pattern and clinical criteria the definition of
seizures includes the following,(13,14)
1. Epileptic seizures: phenomena associated with corresponding EEG
seizure activity e.g. clonic seizures
2.  Non-epileptic seizures: clinical seizures without corresponding
EEG correlate e.g. subtle and generalized tonic seizures
3.  EEG seizures: abnormal EEG activity with no clinical correlation.
Clinical seizure criteria
The international league against epilepsy’s (ILAE) classification
adopted by the world health organization still considers neonatal seizures
within an unclassified category . Another recent classification scheme
suggests a stricter distinction of clinical seizure (nonepileptic) events
from electrographically confirmed (epileptic) seizures with respect to
possible treatment interventions (14). Continued refinement using novel
seizure classifications is needed to reconcile disagreements between
clinical and EEG criteria, which impede a correct seizure diagnosis. More
than one type of seizure can occur in a newborn over time, in many cases.
Broadly speaking, clinical criteria for neonatal seizure diagnosis
were subdivided into five categories(13)
1. focal clonic,
2. multifocal or migratory clonic,
3. tonic,
4. myoclonic, and
5. subtle seizures.
Subtle seizures(13,15) is recently termed  as motor automatisms and
buccolingual movements.It is the most commonly observed type of
neonatal seizures.These are called subtle because of their mild clinical
manifestations  and  are  often  missed.Some  of  the  common  examples  of
subtle seizures include the following.
A. ocular signs include random and roving eye movements or
nystagmus which is distinct from tonic deviation of eyes.
B. oral-buccal-lingual movements include chewing,sucking,tongue
protrusions, lip smacking which may be associated with drooling at
times.
C. various progression movements that are included in subtle seizures
are rowing or swimming movements,pedaling or bicycling
movements of legs,boxing-jabs.complex purposeless movements
like sudden arousal with transient increased random activity of
limbs are also included. ‘
D. Autonomic phenomena like tachycardia or bradycardia can also
occur. Autonomic expressions, however, also are intermixed with
somatic findings. Isolated autonomic signs such as apnea are rarely
associated with coincident electrographic seizures.
Despite the “subtle” expression of this seizure category, affected
children may suffer significant brain injuries.most subtle seizures are not
associated with EEG seizure pattern.
Clonic seizures(13,15) are rhythmic movements of body parts that
are biphasic consisting of a rapid flexion phase followed by a slower
extensor movement. It has to be differentiated from the symmetric “to-
and-fro” movements of nonepileptic tremulousness or jitteriness. These
Clonic seizures may be unifocal, multifocal, or generalized. Among focal
clonic, seizures may occur unilateraly, sequentially in different limbs or
simultaneously but asynchronously. Clonic seizures commonly involve
face, upper or lower limb,eyes,or trunk and are associated with EEG
changes.
Tonic type of seizures(13,15) usually refers to a sustained flexion or
extension of axial or appendicular muscle groups. These seizures may be
focal or generalized. Focal tonic seizures  include sustained posturing of
single limbs, sustained asymmetric posturing of the trunk or sustained eye
deviation whereas generalized tonic involve sustained symmetric
posturing of limbs, trunk and neck which  May involve flexor, extensor,
or mixed extensor/flexor muscle groups.  Usually  there  are  no  EEG
changes in generalized tonic seizures.
Myoclonic(13,15) movements are rapid, isolated jerks involving an
axial or appendicular distribution. They can be focal,multifocal or
generalized myoclonic seizures.these myoclonic jerks are differentiated
from clonic seizures by more rapid speed of myoclonic jerks, absence of
slow return and predilection for flexor muscle groups. Healthy preterm
infants commonly exhibit myoclonic movements without seizures or a
brain disorder. Pathologic myoclonus in the absence of electrographically
confirmed seizures also can occurin severely ill preterm or full-term
infants after severe brain dysfunction or damage. Generalized myoclonus
is most often associated with an EEG seizure pattern whereas focal or
multifocal myoclonic events are not associated with such patterns.
Myoclonic seizures carry the worst prognosis in terms of neuro -
developmental outcome and seizure occurance whereas focal clonic
seizures have best prognosis.
In a study by Yadav et al(11),Subtle seizure was most common type
of fits followed by clonic type of seizures whereas in a study by Najeeb
Et Al(16), the most common type was found to be Tonic clonic seizure
followed by multi-focal clonic, and focal tonic seizure. Birth asphyxia
was found to be the main aetiology.
Similar study by Aziz  et  al(12)has found Focal clonic and subtle
seizures were the commonest seizure types encountered which was
supported by Roshith  et  al(17)on his study on etiological, clinical and
EEG profile of neonatal seizures, where Focal clonic type of seizures was
more observed as compared to other types.
Seizure mimics :(13,15)
In a neonate it may be difficult to differentiate between normal
immature behaviors (e.g., non-nutritive sucking),from abnormal non
epileptic behaviors (e.g., “jitteriness”), and true epileptic patterns. There
are some clinical clues which may help distinguish true epileptic seizures
from seizure mimics.Tremor (jitteriness) are frequently misidentified as
clonic seizure  activity by inexperienced medical personnel. In tremor, the
flexion and extension phases are equal in amplitude, unlike the unequal
phases of clonic movements. Passive flexion and repositioning of the
affected tremulous body part will diminish or eliminate the movement.
Such movements usually are spontaneous but can be provoked by tactile
stimulation and are usually associated with normal interictal examination.
Whereas true seizures are rarely stimulus-sensitive, cannot be
abolished by passive restraint or repositioning of the infants and are often
associated with autonomic changes or ocular phenomena.
Common causes of neonatal seizures
Aetiology of neonatal seizures is variable and can be primarily
related to disorders of brain or secondary to metabolic problems or
cryptogenic. Aetiology of neonatal seizures is identified in 99% of cases
and is rarely idiopathic(18). There are various causes for neonatal
seizures.the most common cause as per the recently published studies in
India are hypoxic ischaemic encephalopathy, metabolic diturbances
(hypoglycemia and hypocalcemia) and meningitis (19,20). The etiology
varies among different centres depending upon the patient population (
preterm vs term) and level of monitoring (only clinical vselectrical and
clinical seizures) etc. The overview of various causes of neonatal seizures
are given below.
CAUSES: (21)
A) Hypoxic-ischemic injury
  Perinatal asphyxia
 Focal infarction/stroke
B) Intracranial hemorrhage
 Intraventricular
 Parenchymal
Subdural
Subarachnoid
C) CNS infection
D) Malformations and other structural lesions
 Neuronal migration disorders
Cerebral dysgenesis
Neurocutaneous disorders (e.g.,Sturge-Weber syndrome,
tuberous sclerosis)
E) Acute metabolic disorders
 Hypoglycemia
  Hypocalcemia
  Hypomagnesemia
  Hyponatremia
F) Inborn errors of metabolism
 Aminoacidopathies
Organic acidurias
 Peroxisomal diseases
 Mitochondrial disorders
Disorder of glucose transport (GLUT-1 deficiency)
G) Epilepsy syndromes
 Benign familial syndromes
Severe neonatal epileptic encephalopathies
Pyridoxine (Vitamin B)-dependent seizures
Folinic acid responsive seizures
Park  Weon  et  al (22) in his study has found out that the most
common cause of  neonatal seizure being hypoxic ischemic
encephalopathy (32.9%), hypocalcemia (20.5%), hypoglycemia (9.6%),
sepsis (9.6%), benign idiopathic neonatal seizure (6.8%), intracerebral
hemorrhage(5.5%), hyponatremia (1.4%), hypernatremia(1.4%),
kernicterus, hyper-ammonemia, in order of frequency. The most common
type of neonatal seizures being subtle followed by generalized tonic ,
focal clonic , multifocal clonic , focal tonic, and myoclonic in order of
frequency.  On follow up examination,some of the babies are found to
have neurologic sequalae , recurrent seizures , cerebral palsy and other
combined neurologic problems
Aziz  et  al(12) in  his  study  on  clinical  and  etiological  profile  on
neonatal seizures has found Cumulative frequency of 3.9% in neonatal
seizures . Hypoxic ischemic encephalopathy was the commonest etiology
of neonatal seizures. Intracranial haemorrhage followed by Hypoxic
ischemic encephalopathy was the commonest seizure etiology in preterm
neonates. Majority of Hypoxic ischemic encephalopathy patients
presented with seizures in the first 72 hrs. of life. Focal clonic and subtle
seizures were thecommonest seizure types encountered. 17 neonates
(31%) had primary metabolic seizures. Hypocalcaemia was the
commonest biochemical abnormality in primary metabolic seizures and
was present in 70% neonates in this group. Hypoglycemia was the next
commonest abnormality and was present in 41% neonates within this
group.
Anand  et  al(23) in his study on neonatal  seizures has concluded
that incidence of neonatal seizurewas 5.5%. Hypoxic ischemic
encephalopathy (HIE) and sepsis constituted the most common etiologies.
HIE was the most common etiology associated with mortality. Abnormal
EEG with supressed background activity was present in majority of
mortality cases.
Mwaniki, Michael Et Al (24)in his study on "Neonatal seizures in
a rural Kenyan District Hospital has reported Seizures in 142/1572
(9.0%) of neonatal admissions. The incidence was 39.5  per 1000 live-
births and incidence increased with birth weight. The main diagnoses in
neonates with seizures were sepsis in 85 (60%), neonatal encephalopathy
in 30 (21%) and meningitis in 21 (15%), but only neonatal
encephalopathy and bacterial meningitis were independently associated
with seizures. Neonates with seizures had a longer hospitalization
compared to those without seizures. Overall, there was no difference in
inpatient case fatality between neonates with and without seizures but,
when this outcome was stratified by birth weight, it was significantly
higher in neonates ? 2.5 kg compared to low birth weight neonates . Up
to 13% of the surviving newborn with seizures had neurological
abnormalities at discharge.
Nunes et  al(25) during the study on 3659 newborns, seizures were
observed in 2.7% . Hypoxic ischemic encephalopathy (51%) was the
etiology more frequently associated to seizures and also to post-neonatal
epilepsy (53%). In the follow up 25 died during the acute neonatal illness
and 9 during the first years of life, 19 were diagnosed as having post
neonatal epilepsy, 35 had developmental delay and 11 an association
among this two comorbidities. A significant association betweenabnormal
postnatal EEG and neuroimaging to developmental delay (p=0.014,
p=0.026) was observed. The groupof newborns that had seizures
presented an increased risk of developing epilepsy compared to newborns
from the same cohort without seizures.
Balaka et al(26) in his prospective one year study in paediatric
department of University Hospital, Togo had observed the cumulative
frequency of seizures was about 7.1%,which included 192 males and 152
females. The seizures frequency in newborn 0-21 days was 95.9% and
was 52.6% in neonates < 1day. The focal seizures were reported in 68%
follow by generalized tonic-clonic in 24.4%. The aetiologies were
marked by neonatal brain injuries and perinatal asphyxia. Sixteen
neonates with seizures were died giving a direct mortality rate of 4.7%.
Eight (2.3%) surviving newborns had heavy neurodevelopmental deficits
at discharge.
Omene et al(71) in his prospective study of 55 infants with neonatal
seizures  admitted  to  the  Special  Care  Baby  Unit  of  the  University  of
Benin Teaching Hospital over a 5.5-year period revealed that perinatal
asphyxia and hypoglycemia were the principal aetiologic factors in about
71% of the cases. The most frequently encountered seizure types were
unilateral clonic (51.5%). Generalized clonic and massive generalized
myoclonic seizures were found in 14 (25.5%) and seven (12.7%) cases,
respectively, and subtle seizures in three.The overall incidence
was 3.5/1000 live births, with a preponderance of male infants in the
seizure population, among whom preterm infants were significantly more
common. He further stated that the mortality (34.5%) was closely related
to the etiology and since the associated adverse perinatal events are
largely preventable, improved prenatal and perinatal health care delivery
should lead to a decline in the frequency of neonatal seizures. (71)
1.Acute Metabolic Disorders
Acute metabolic disorders are rapidly remediable conditions and
are the focus of the initial investigations in neonatal seizures. They
account for ~5% of neonatal seizures.(21). The common causes include
1.Hypoglycemia,
2. Hypocalcemia,
3. Hypomagnesemia,And
4.Hyponatremia.
Hypoglycemia
There is no universal definition for hypoglycemia (27). Various
investigators have empirically recommended different blood glucose
levels (BGLs) that should be maintained in neonatal period to prevent
injury tothe developing brain.(28,29) The “normal” range of blood glucose
is variable  and depends upon factors like birth-weight, gestational age,
body stores, feeding status, availability of energy sources as well as the
presence or absence of disease (30,31). Further, there is no concrete
evidence  to  show  the  causation  of  adverse  long-term  outcomes  by  a
particular level or duration of hypoglycemia(32). Hence, a consensus has
been to evolve an “operational threshold”.
The operational threshold for hypoglycemia is defined as that
concentration of plasma or whole blood glucose at which clinicians
should consider intervention, based on the evidence currently available in
literature (33).
“Operational threshold has been defined as Blood glucose
levels of less than 40 mg/dL (plasma glucose level less than 45 mg/dL)
(34) whereas WHO defines hypoglycemia as blood glucose levels of less
than 45 mg/dL.”
Most hypoglycemic infants are asymptomatic, but at any point,
symptoms of neuroglycopenia should prompt immediate treatment. These
are jitteriness, tremor, apathy, weak and high pitched cry, hypotonia,
alteration of consciousness, poorfeeding, apnea, and seizures. Episodes of
sweating, sudden pallor, hypothermia and cardiac arrest have alsobeen
reported.
Methods of glucose determination (i.e., point of-care Blood
sampling versus laboratory serum sampling) will affect the accuracy of
thevalue. Also associated disturbances may coexist, such as
hypocalcemia, cranio-cerebral trauma, cerebro-vascular lesions, and
asphyxia, which may contribute to lowering the threshold for seizures.
Infants born to diabetic or pre-eclamptic mothers, particularly those
who were small for gestational age, also are at risk for hypoglycemia.
Cerebrovascular lesions in posterior brain regions have been reported in
children who suffer hypoglycemia (35).
Other Causes of neonatal hypoglycemia include decreased glucose
supply,as in the premature and small-for-gestational-age infant, as well
asdisorders in which pathways of gluconeogenesis are deficient or
suppressed (e.g.,glycogen storage disorders, aminoacidopathies suchas
maple syrup urine disease,fatty acid oxidation defects),and increased
utilization, such as in hyperinsulinemic states, most commonly seenin the
infant of the diabetic mother. Other hyperinsulinemic states include the
overgrowth syndrome Beckwith-Wiedemann syndrome, erythroblastosis,
and the rare hyperinsulinemic hypoglycemia.
There is a paucity of the literature that looks into optimal timing
and the intervals of glucose monitoring.Lowest blood sugar values are
seen at 2 hours of life.
IDMs frequently experience asymptomatic hypoglycemia very
early viz. 1 to 2 hours and rarely beyond 12 hours (range 0.8 to 8.5 h),
supporting need for early screening for this population (36). However,
preterm and SGA may be at highest risk up to 36 h (range 0.8 to 34.2 h)
(37)
Diagnosis of hypoglycemia
1. Asymptomatic hypoglycemia : is said to be present when BGL is
less than 45 mg/dL (to be confirmed by laboratory estimation) and the
infant does not manifest with any clinical features
2.Symptomatic hypoglycemia: should be diagnosed if
hypoglycemia (Blood glucose level is less than 45 mg/dL) coexists with
clinical symptoms. Neonates generally present with nonspecific signs that
result from a variety of illnesses. Therefore, careful evaluation should be
done to look for all possible causes especially those that can be attributed
to hypoglycemia. If clinical signs attributable to hypoglycemia persist
despite intravenous glucose, then other causes of persistent / resistant
hypoglycemia should be explored.
Management of symptomatic hypoglycemia
All symptomatic infants should be treated with IV fluids. For
symptomatic hypoglycemia including seizures, a bolus of 2 mL/kg of
10% dextrose (200 mg/kg) should be given. This mini-bolus helps to
rapidly correct blood glucose levels (38). This bolus should be followed
by continuous glucose infusion at an initial rate of 6-8 mg/kg/min. Blood
glucose levels should checked after 30 to 60 min,  and then every 6 hour
until the blood sugar is >50 mg/dL.
If BGL stays below 45 mg/dL despite bolus and glucose
infusion,the  glucose infusion rate (GIR) should be increased in steps of 2
mg/kg/min every 15 to 30 min until  maximum of 12 mg/kg/min. After 24
hours of IV glucose therapy, once two or more consecutive BGLs are >50
mg/dL, the infusion can be tapered off at the rate of 2 mg/kg/min every 6
hours with repeated blood glucose level monitoring. Tapering has to be
accompanied by concomitant increase in oral feeds. Once a rate of 4
mg/kg/min of glucose infusion is achieved and the oral intake is adequate
and the BGLs are consistently >50 mg/dL, then the infusion can be
stopped.  It is important to ensure that the continuous glucose infusion is
given preferably using an infusion pump and without any interruption.
We should not stop glucose infusion abruptly as severe rebound
hypoglycemia may occur and we should Avoidusing more than 12.5%
dextrose infusion through a peripheral vein due to the risk of
thrombophlebitis.
Sood et al (39) in his study on biochemical abnormalities of
neonatal seizures has observed the following findings. Primary metabolic
abnormalities occurred in 10(16.94%) cases of neonatal seizures, most
common being hypocalcaemia followed by hypoglycemia, other
metabolic abnormalities include hypomagnesaemia and hyponateremia.
Biochemical abnormalities were seen in 19(38.77%) cases of non
metabolic seizure in neonates. Associated metabolic abnormalities were
observed more often with Hypoxic-ischemic encephalopathy (11 out of
19) cases and hypoglycemia was most common in this group.
Yadav et al (11) in his study has found out Hypocalcemia was most
common biochemical derangement followed by hypoglycemia,
hypomagnesimia and hyponatremia respectively.
Dinesh Das et al (40), in his study on biochemical abnormalities in
neonatal seizures has stated Hyponatremia is the most Common
biochemical abnormality associated with non-metabolic Seizures, mainly
HIE. Hypoglycemia is a more common metabolic Disorder, more so in
low birth weight. Incidence of hypomagnesemia with hypocalcemia is
low but has occurred.
Griffith et al (35) in his observation has found Vulnerability of
brain to ischemic insults is enhanced by concomitant hypoglycemia, as
reported in mature animals and neonatal infants.
Hypocalcemia
Calcium (Ca) is actively transferred from  mother to the fetus
during last  trimester, as demonstrated by  a  significantly higher levels of
total calcium concentration in cord blood compared to maternal serum
levels(41).
Parathyroid hormone (PTH) and calcitonin (CT) donot cross the
placental barrier. Hence PTH related peptide (PTHrP) is the main
regulator of  positive Calcium balance across the placenta. Serum Ca
(SCa) in the fetus is 10 to 11 mg/dL at term (1 to 2 mg/dL higher as
compared to mother). After birth, the Serum Ca levels in newborns
depend on PTH secretion, dietary calcium intake, renal calcium re-
absorption,  and  the  skeletal  calcium and  vitamin  D status.   Hence,  after
delivery, serum calcium levels start decreasing (the rate and the extent of
decrease is inversely proportional to the gestation) and reaches a nadir of
7.5 to 8.5 mg/dL in healthy term babies by day 2 of life. This postnatal
drop in SCa may be related to decreased PTH level, end organ
unresponsiveness to PTH(42), abnormalities of vitamin D metabolism,
hyperphosphatemia, hypomagnesemia, and hypercalcitonemia, which
may occur by 12-24 hoursof age(43). PTH levels increase gradually in first
48 hours of life and normal levels of SCa are achieved by 3rddayof life(44).
The efficacy of  intestinal absorption and the renal handling of Ca mature
by 2 to 4 weeks.This transition phase is responsible for the increased risk
of early onset hypocalcemia in high-riskneonates.
“Hypocalcemia is defined by different total serum calcium and
ionized  serum  calcium  cutoffs  for  preterm  and  term  infants  .  In
preterm, total serum calcium levels <7 mg/dl and in term total serum
calcium levels less than 8mg/dl is defined as hypocalcemia”.(45)
There are two types of hypocalcemia,
     1.Early onset hypocalcemia and
     2. Late onset hypocalcemia
Early-onset hypocalcemia occurs in the first 3-4 days of life and
is associated with prematurity, infants of diabetic mothers, intrauterine
growth retardation and perinatal asphyxia. Most cases are asymptomatic.
Late-onset (>  10  days  of  life) hypocalcemia causes include
hypoparathyroidism, the feeding of high-phosphate formula, Digeorge
syndrome (chromosome 22q11-pter deletion), some mitochondrial
cytopathies and hypomagnesemia. Symptomatic or persistent cases of
hypocalcemia should be treated promptly.
Lynch and rust et al(46) in their study on 1994 has found that both
hypocalcemia and hypomagnesemia precipitates seizures whereas Keen
Et Al(47) has cited Late-onset hypocalcemia due to use of highphosphate
infant formula as a common cause of seizures
Clinical presentation
Asymptomatic: Early neonatal hypocalcemia is usually
asymptomatic unlike the late onset variety and is incidentally detected.
Symptomatic: The symptoms are related to neuromuscular
irritability like myoclonic jerks, jitteriness,exaggerated startle reflexes,
and seizures. They may represent the cardiac involvement like-
tachycardia, heart-failure, prolonged QT interval, decreased
contractibility of heart. More often they are non-specific and are not
related to the severity of hypocalcemia. Apnea, cyanosis, tachypnoea,
vomiting and laryngospasm are some of the other symptoms that are
noted. Laboratory diagnosis is made by measuring total or ionized serum
calcium
Treatment
Infants detected to have hypocalcemia on routine screening and
who are otherwise asymptomatic should receive 80-mg/kg/day of
elemental calcium (8mL/kg/day of 10% calcium gluconate) for 48 hours
period . This may be tapered to 50% dose for another 24 hours and then
may be discontinued. Neonates who are able to tolerate oral feeds may be
treated with oral preparations of calcium.
Infants diagnosed to have symptomatic hypocalcemia should
receive a bolus dose of 2 mL/kg/dose diluted 1:1 with 5% dextrose over
10 minutes under strict cardiac monitoring. When features of severe
hypocalcaemia with poor cardiac function is noted, calcium chloride 20
mg/kg may be given through a central line over 10-30 minutes (as
chloride in comparison to gluconate does not require themetabolism by
the liver for the release of free calcium). This should be followed by a
continuous IVinfusion of 80 mg/kg/day of elemental calcium for atleast
48 hours. Continuous infusion is preferred over IV bolus doses (1
mL/kg/dose q 6 hourly). Calcium infusion should be dropped to 50% of
original dose for the next 24 hours and then can be discontinued. The
infusion may be replaced with oral calcium therapy on the lastday.
Normal calcium values should be documented at 48 hours before weaning
of the infusion.  All categories of hypocalcemia should be treated for at
least 72 hours. Continuous infusion is preferred to IV bolus doses.
Symptomatic hypocalcemia should be treated with a continuous infusion
for at least 48hours.
Aziz et al(12) in his study ,17 neonates (31%) had primary metabolic
seizures. Hypocalcaemia was the commonest biochemical abnormality in
primary metabolic seizures and was present in 70% neonates in this
group.   Hypoglycemia  was  the  next  commonest  abnormality  and  was
present in 41% neonates within this group.
Park Weon et al(22) in his study on neonatal seizures has found
HIE as the most common etiology. Among metabolic causes,
hypocalcemia to be most common biochemical abnormality followed by
hypoglycemia and hyponatremia.
Hyponatremia and hypernatremia
Hyponatremia is defined as serum sodium levels less than 135
mEq/l. It is a metabolic disturbance that may result from inappropriate
secretion of antidiuretic hormone aftersevere brain trauma, infection, or
asphyxia (13) but is an uncommon isolated cause of neonatal seizures.
Eril  et  al(48) in his study has observed Hyponatremia, besides
causing seizures, is also known to result in adverse neurological
developmental outcomes like increased risk of cerebral palsy and
increased risk of hearing loss.
Hypernatremia is defined as serum sodium levels > 145 mEq/l.
It is a rare cause of seizures, usuallyassociated with congenital adrenal
abnormalities or iatrogenic disturbance of serum sodium balance, from
the use of intravenous fluids with high concentrations of sodium.
In a study done by Dinesh Das et al(40), Hyponatremia is the most
Common biochemical abnormality associated with non-metabolic
Seizures, mainly HIE.
Hypomagnesemia
The most common cause is transient neonatal hypo-magnesemia.It
causes parathyroid hormone resistance and so, causes hypocalcemia.
Hypomagnesemia must be corrected before the hypocalcemia can be
corrected. Levels<1.4 mg/dL (<0.6 mmol/L) are considered low (21).
Theneonate should receive 2 doses of 0.2 mL/kg of 50% MgSO4
injection, 12 hours apart, deep IM followed by a maintenance dose of 0.2
mL/kg/day of 50% MgSO4 per oral for 3 days.
2. Hypoxic- ischaemic encephalopathy
This is the most common cause of neonatal seizures, accounting for
over 50% of cases (21). HIE can be global, as in perinatal asphyxia or focal
(i.e., arterial infarction). In perinatal asphyxia, the seizures occur in the
context of a newborn whohas a history of difficult labor and delivery with
alterations  in the fetal heart rate, decreased umbilical artery pH, and
Apgar score of <5 at 5 minutes. There is typically early suppression of the
mental status, sometimes associated with coma and low tone, in addition
to the seizures. Neonatal seizures due to hypoxic ischaemic
encephalopathy  are often seen withinthe first 12 to 24 hours. Although
the insult is global, the seizures are usually focal and may be multifocal.
They are typically of short duration ( < 1 minute) but may be very
frequent and refractory, especially in the first 24 hours. Treatment is
urgent and in many infants complicated by the effects of hypoxic injury
to the other organ systems (hepatic, pulmonary, renal, cardiovascular). In
Addition, the anticonvulsant drugs may also contribute to hypotension
and hypoventilation.
Another concern is the possibility of unidentified electrographic
seizures occurring in infants with HIE. This is particularly important
following treatment with anticonvulsant drugs, which may eliminate
clinical events but allow continuing electrographicseizures
(electroclinical dissociation). Where possible, prolonged EEG is
invaluable in identifying on going subclinical seizures. In focal ischemic
lesions, such as middle cerebral artery stroke, in contrast, the infant
usually appears well and presents with focal clonic seizures. Such arterial
strokes may have occurred prior to, or in early labor. Asymmetries of the
motor examination are often lackingin these infants, and diagnosis may
be delayed until later in their first year if they do not present with
neonatal seizures.
Ronen et al, Lanska et al And Saliba et al in their various studies
have observed that the most common cause of neonatal seizures being
hypoxic-ischemic encephalopathy, which occurs in approximately 1 to 2
per 1,000 live births. (49-51)
In a recently reported study from a tertiary care referral neonatal
intensive care unit by Tekgul et al, about two thirds cases were
associated with hypoxic-ischemic encephalopathy or cerebrovascular
disorders. Infants with neonatal encephalopathy as a result of hypoxia-
ischemia are at particularly high risk for seizures as suggested by above
studies. (52)
In yet another two recent clinical trials by Shankaran Et Al and
Gluckman Et Al(53,54) on hypothermia for treatment of neonatal hypoxic-
ischemic encephalopathy, stated that seizures were frequent at the time of
randomization (40 –60%).
3. Intracranial hemorrhages (ICHs)
Intracranial hemorrhages are responsible for 10% to 15% of
neonatal seizures.In the term infant, primary subarachnoid hemorrhage is
probably the more common site. Most are not of clinical significance and
produce no symptoms. Normal or instrumental deliveries and/or trauma
may be associated with more substantial subarachnoid hemorrhages,
which may present with seizures, usually on second day of life. These
infants appear clinically well between the seizures and have a very good
outcome. Subdural hemorrhagesare related to large size of infant , breech
delivery, and instrumentation.They are due to tears in the falx, the
tentorium, or the superficial cerebral veins.They are often associated with
underlying cerebral contusions, which may be responsible for seizures in
some cases. Presenting seizures are usually focal and occuring the first
few days of life. If large, subdural hematomas May be treated by surgical
means making diagnosis important. In the preterm infant, germinal
matrix, intraventricular and parenchymal hemorrhages are the prototypic
sites of involvement of premature hypoxic injury. EEG has identified
subclinical electrographic seizures in association with these hemorrhages.
Seizures occurring in the setting of premature hemorrhagic lesions are not
usually associated with a good outcome.
Mercuri et al and Scher et al in their studies has said that
Cerebral infarction and stroke the second most common cause of neonatal
seizures  which  occurs  in  otherwise  well  term infants,  without  history  of
previous risk factors  and involves left middle cerebral artery territory and
presents with right sided clonic seizure. (55,56)
Sheth et al and Scher et al in their study on neonatal seizures has
implicated intracranial hemorrhage as a cause in 10% to 15% of seizures,
and amongst them Intra-ventricular hemorrhage or Periventricular
hemorrhagic infarction is the most common Intracranial hemorrhage in
preterm infants and constitutes around45% seizures in preterm. (57,58)
4. CNS infections
CNS infections account for about 5% of neonatal seizures.
Congenital intrauterine infections, such as with cytomegalovirus ( CMV),
toxoplasma,rubella, and herpes viruses may present early (first 2 days)
with seizures in severe cases. The clinical scenario may include
microcephaly, poor intrauterine growth, prematurity, and other skin,
ophthalmic, and systemic findings.Meningoencephalitis, cerebral
calcification, and dysgenesis (in cases of early intrauterine infection)
contribute to the pathogenesis of seizures in these cases. Postnatal sepsis,
for example, with group B Streptococcus or Escherichia coli, is often
complicated by meningitis and may be associated with seizures. In this
setting, the newborn has often been well for a coupleof days, only to
deteriorate later with seizures occurring after the first 48 to 72 hours.
5. Malformations/structural lesions
Five percent of neonatal seizures are causedby cerebral
dysgenesis.Cerebral dysgenesis can cause seizures from the first day of
life. This is most likely with the more severe disorders, such as hemi-
megalencephaly, lissencephaly, and polymicrogyrias. Seizures are often
very refractory to medications. Some disorders may be amenable to
surgical treatments, such as hemi-megalencephaly and focal
polymicrogyrias. In general, these infants are not encephalopathic
interictally. On occasion, clues to neurocutaneous diseases are apparent
on the newborn examination-for instance, the hemangioma in the
distribution of cranial nerve V1 in Sturge-Weber syndrome, which can
occasionally cause seizures in the newborn period. Depigmented "ash-
leaf'' macules of tuberous sclerosis may be seen, although neonatal
seizures are rare in this disorder. Neuroimaging is primary in making
these diagnoses.
6.Epileptic syndromes in the newborn infant
    a)Benign familial neonatal seizures
    b)Benign idiopathic neonatal seizures
   c) Neonatal myoclonic encephalopathy (NME)
   d)Ohtahara syndrome
   e)Migrating partial seizures of infancy (Coppola syndrome)
PROGNOSIS AND OUTCOME
Neonatal seizures can result in significant neonatal mortality and
morbidity. The outcome and prognosis depends upon the etiology of
neonatal seizures which was supported by various studies.
A study by Holden et  al(59)which is  one of  the first  studies of  the
prognosis of neonatal seizures was a review of 277 newborns with
seizures enrolled in the collaborative perinatal project. In this group, there
was 35%Mortality, and 30% of survivors had adverse neurological
Outcomes at age 7 years, including cerebral palsy(13%), intelligence
quotient less than 70 (19%), and epilepsy(20%), alone or in combination
Laroia et al(60) in his study has observed that overall 10-
50%patients die and 50% develop long term complications like
epilepsy,cerebral palsy and mental retardation. Outcome is predicted by
the underlying etiology which was further supported by zupanc et al in
his study.Patients with hypoxic ischemic encephalopathy (HIE),intra-
ventricular haemorrhage and structural brain malformation have the worst
prognosis ,While those with transient metabolic abnormalities and benign
idiopathic or familial aetiologies have the best prognosis.
Ronen et al (61)in his study has found that the outcome of
prolonged neonatal seizures can include later life consequences in over
30% of survivors, with cognitive deficits ranging from learning disability
(27%) to developmental delay and mental retardation (20%), as well as
later life epilepsy (27%) which was similar to observations by Jensen et
al,  Schmitt  et  al  And Idro et  al where the outcome of seizures in over
30% of survival neonates were marked by neurodevelopmental and
cognitive deficits and later life epilepsy. (62-64)
Tekgul et al(52) in his study on 89 term infants with neonatal
seizures has observed that there was markedly less neonatal mortality
(7%), but a remarkably similar degree of poor long-term neurological
outcome in 28%.
Verloove-Vanhorick et al(65) in a nationwide, prospective survey
on very preterm and/or very low birthweight infants ( < 32 weeks of
gestational  age and/or < 1500 g birthweight)has  studied the outcome at
the corrected age of two years of children with neonatal seizures.Of the
1338 infants, originally enrolled in the study, 72 had neonatal seizures; of
these 44 died and 11 developed a major handicap. Using a multivariate
statistical method, he further stated that there was a significantly
increased risk of death as well as handicap was found in infants with
seizures compared to infants without seizures. Nevertheless, 16 of the 28
survivors with neonatal seizures were considered normal at the corrected
age of two years.
Dennis et al (66) in his  study on “Neonatal Convulsions: Aetiology,
Late Neonatal Status and Long-Term Outcome” has followed up the
children with neonatal seizures for four years and found  the outcome at
the age of four years as follows, 26 per cent are dead; 33 per cent show
adverse sequelae; 5 per cent are of questionable status; and 36 per cent
appear to be normal. A wide range of handicap is present among the
sample. Seizures have recurred in 20 per cent of all children surviving the
neonatal period.If definite normality or abnormality was predicted in an
individual child at the neonatal discharge assessment, the prediction was
found to be correct at age four years. Subsequent assessments in the first
year of life were of less predictive value for the individual child.
Brunquell,  Philip  J.,  et  al.(67) in  his  study  on  Prediction  of
outcome based on clinical seizure type in newborn infants has found that
Twenty-three (30%) died; 59% of the survivors had abnormal neurologic
examinations, 40% were mentally retarded, 43% had cerebral palsy, and
21% were epileptic at mean follow-up of 3.5 years. Compared with
patients with other seizure types, those with subtle and generalized tonic
seizures had a significantly higher prevalence of epilepsy (P =.04
and P =.01 respectively); mental retardation (P =.02; P =.007), and
cerebral palsy (P =.03; P =.002). Subtle seizures were, in addition, more
likely to be associated with abnormalities on the neurologic examination
at follow-up (P =.03). Similar outcome comparisons for those with focal
and multifocal clonic, focal tonic, and multifocal myoclonic seizures
revealed no significant differences. However, patients with ?2 seizure
types were significantly more likely to have epilepsy (P =.02), mental
retardation (P =.001), cerebral palsy (P=.001), and abnormal examinations
(P =.05).
Davis, Alexis S., et al.(68) observed in his study that Infants with
clinical seizures had a greater proportion of neonatal morbidities
associated with poor outcome, including severe intraventricular
hemorrhage, sepsis, meningitis, and cystic periventricular leukomalacia
(all P < .01). Survivors were more likely to have Neurodevelopmental
impairment or moderate-severe cerebral palsy at 18 to 22 months
corrected age (both P < .01). After adjusting for multiple confounders,
clinical seizures remained significantly associated with late death or
neurodevelopmental impairment, thereby concluding that ELBW infants
with clinical seizures are at increased risk for adverse
neurodevelopmental outcome, independent of multiple confounding
factors.
Pisani et al(69)in his study evaluated perinatal risk factors,
electroencephalogram (EEG) findings and ictal semeiological
characteristics of newborns with neonatal seizures in order to identify
which clinical variables were the most early predictive factors of poor
neurodevelopmental outcome and of epilepsy. Among all preterm infants
consecutively admitted to the neonatal intensive care unit (NICU) of the
University Hospital of Parma in the period between January 1999 and
June 2003, 28 preterm infants with gestational age ??36 weeks were
selected according to the presence of repetitive neonatal seizures, need of
chronic anticonvulsant therapy, more than one EEG performed during the
neonatal period, and at least one imaging examination (cerebral
ultrasound and/or cerebral magnetic resonance imaging (MRI). These
patients were prospectively followed up for at least 6 months to evaluate
the clinical outcome. Independent variables considered for analysis
included perinatal risk factors, etiology of convulsions, EEG activity and
type of seizures.in his study he made the following observations. The
background EEG activity was the strongest predictive factor of the
neurodevelopmental outcome, but status epilepticus (SE) also represented
a significant variable associated with poor prognosis and subsequent
epilepsy.
Watkins  et  al(70) in his study on 506 very low-birthweight
(VLBW) infants, reviewed data on 67 identified as having seizures. 29
survivors with seizures and 305 without were followed up at the ages of
one, two and five years: statistical significance of psychological and
mental impairment was evaluated. Impairment was higher in the seizure
group at 66 per cent (15 per cent in non-seizure group) and 43 per cent of
these were considered to be severely impaired. Infants with seizures
occurring for more than seven days and lasting for more than five minutes
had the poorest outcome, and infants with late onset had the best
outcome.  Analysis  showed  that  40  per  cent  of  seizures  were  caused  by
birth asphyxia, and these were strongly prognostic, correlating with
mortality and impairment rates.  60 per cent  of  the infants  who died had
the same cause for both their seizures and death, and for 57 per cent of
these the cause was perinatal asphyxia. The poor outlook for the VLBW
infants suggests that the seizures themselves are a seríous neurological
insult.
MORTALITY AND MORBIDITY
With improved heath care and early identification and treatment of
neonatal seizures,the death due to neonatal seizures has drastically
decreased but the long term morbidity and neurological sequale has
increased depending upon the etiology of neonatal seizures.
Holden  et  al(59) in his study has reported the risk of mortality as
approximately 35% but recent studies by Tekgul  et  al and Ronen et al
on term infants with clinical seizures has demonstrated a lower neonatal
mortality of less than 20% due to improvements in neonatal intensive
care. (52,61)
Tekgul et al further concluded in his studies that Mortality
associated with neonatal seizures has declined although long-term
neurodevelopmental morbidity remains unchanged. Seizure etiology and
background EEG patterns remain powerful prognostic factors. Diagnostic
advances have changed the etiologic distribution for neonatal seizures
and improved accuracy of outcome prediction. Global cerebral hypoxia-
ischemia, the most common etiology, is responsible for the large majority
of infants with poor long-term outcome.
Shin  et  al(76) in  his  study  aimed  to  evaluate  the  usefulness  of
scoring prognostic factors and its efficacy as a prognostic index.his study
included 67 neonates who were admitted to Chungnam National
University Hospital from January 1999 to April 2005 for seizures which
occurred within 28 days of birth. These patients were investigated
retrospectively from the hospital records. he scored clinical
manifestations including gestational age, birth weight, Apgar score at 5
min, etiology, type, onset, duration, and frequency of seizures, neurologic
examination results, EEG background activities, and treatment responses.
Follow-up examinations were done to analyze the presence of epilepsy
and neurologic deficits. A sum of the factors associated with outcomes
regarded as a prognostic index, were studied in which 50 cases(74.6%)
showed normal outcomes, while 7 cases(10.4%) had unfavorable
neurologic outcomes and 4 cases(6.0%) favorable neurologic outcomes
with epilepsy. 6 cases(9.0%) showed unfavorable neurologic outcomes
with epilepsy. All of the data including gestational age, Apgar score at 5
min, etiology, type, duration, and frequency of seizures, neurologic
examination results, EEG background activities, and treatment responses
were  used  as  a  prognostic  index  by  a  scoring  system.  When  the  cut-off
point was 7, sensitivity, specificity, positive predictive value and negative
predictive value were 76.5%, 78.0%, 54.2%, and 90.7% respectively.
Thus he concluded his study by stating that a scoring system for neonatal
seizures earned high scores in sensitivity, specificity and negative
predictive value, so that it seems to be useful as a predicitive prognostic
index.
MATERIALS AND METHODS
SOURCE OF DATA AND PLACE OF STUDY
 All  the  neonates  from  birth  to  28  days  of  life  satisfying  the
inclusion and exclusion criteria who got admitted in the Neonatal
Intensive Care Unit of Department of Paediatrics, Government Kilpauk
Medical College And Hospital, Chennai, India during the study period
were enrolled in the study.
TYPE OF STUDY
Prospective hospital based observational study
STUDY PERIOD
This study was conducted over a period of 6 months from April
2017 to September 2017.
SAMPLE SIZE: 70
SAMPLE SIZE CALCULATION
Sample size was determined based on “A Study on Clinico-
Biochemical Profile of Neonatal Seizure” authoured by Dinesh Das et al
published in J Neurol Res. 2016;6(5-6):95-101.
In this study, the most common biochemical abnormality detected in
neonatal seizures in our study was hyponatremia (26, 65%).
Description:
• The confidence level is estimated at 95%
• with a z value of 1.96
• the confidence interval or margin of error is estimated at +/-12
• Assuming p% =65 and q%=35
n = p% x q% x [z/e%] ²
n= 65x 35 x [1.96/12]²
n= 60.69 (rounded to 61)
With Attrition 10% = 61+6=67
Therefore 67 is the minimum sample size required for the study
assuming 80% as the power of study.
INCLUSION CRITERIA
All Term and preterm babies presenting  with seizures including
both intramural and extramural neonates were enrolled in the study.
EXCLUSION CRITERIA
Neonates with the following were excluded from the study,
Babies already on anticonvulsant therapy.
Mothers or caregivers not giving consent for the study.
Nature of the study
Written informed consent was taken from the parent or caregivers
prior to the enrolment of neonate for the study. Detailed antenatal history
like, maternal age, past medical history, parity, gestational age, history of
illness during pregnancy, medication during pregnancy, natal history like,
evidence of fetal distress, Apgar score, type of delivery, and medication
given to mother during delivery and perinatal history were recorded.
Baseline characteristics of all the babies were noted on the
prescribed proforma which includes name, age, sex, address weight,
length, head circumference, gestational age, which is determined from
mother by last menstrual period or ultrasound study of fetus before birth
or by new Ballard scoring of the neonate. Thorough physical examination
was done and seizures were diagnosed by clinical observation . Clinical
details of each seizure episode were recorded like age at onset of seizures,
duration of seizure, number and type of seizure. Seizure was classified
into subtle, focal clonic, multifocal clonic, tonic, and myoclonic as per
criteria by Volpe.
Before instituting specific treatment, 3ml of blood will be collected
by sterile technique in a sterile test tube for following investigations like
blood glucose, total serum calcium levels, serum sodium and serum
magnesium levels apart from capillary blood glucose estimation by
glucostrix method.
Random blood glucose was done using glucometer and values were
confirmed by estimating plasma glucose levels by glucose oxidase
method. Serum sodium and potassium estimation done by ion selective
method, Serum total calcium by Arsenazo-3 method, Serum magnesium
by Calmagite method with the support of Department Of Biochemistry,
Government Kilpauk Medical College Hospital, Chennai, India.
CRITERIA FOR DIAGNOSING VARIOUS BIOCHEMICAL
ABNORMALITIES :(4,34,45)
? Hyponatremia:           <135 mEq/l
? Hypernatremia :         >145 mEq/l
? Hypoglycaemia :       <40mg/dl (capillary blood)
                                   <45 mg/dl (venous blood)
? Hypocalcemia :          <7mg/dl for preterm neonates
                                    <8 mg/dl for term neonates
? Hypomagnesemia :     <1.5mg/dl
? Hypermagnesemia :    >2.5mg/dl
? Hypokalemia:            <3.5 mg/dl
? Hyperkalemia:           >5.5 mg/dl
Statistical analysis
Data was recorded on MS Excel sheets and analysis has been made
as given below,
Descriptive analysis: Descriptive analysis was carried out by mean
and standard deviation for quantitative variables, Number and proportion
for categorical variables. Data was also represented using appropriate
diagrams like bar diagram, pie diagram and box plots.
Quantitative outcome;
The association between categorical explanatory variables and
quantitative outcome was assessed by comparing the mean values. The
mean differences along with their 95% CI were presented. Independent
sample t-test/ ANOVA/Paired t- test was used to assess statistical
significance. Association between quantitative explanatory and outcome
variables was assessed by calculating person correlation coefficient and
the data was represented in a scatter diagram. Liner regression analysis
was done. Regression coefficient, along with its 95% CI and p values are
presented.
Categorical outcome
The association between explanatory variables and categorical
outcomes was assessed by cross tabulation and comparison of
percentages. Odds ratio along with 95% CI is presented. Chi square test
was used to test statistical significance.
P value < 0.05 was considered statistically significant.  IBM SPSS
version 22 was used for statistical analysis.(87)
OBSERVATION AND RESULTS
A total of 70 neonates with seizures admitted to the neonatal unit
of Department Of Paediatrics, in Government Kilpauk Medical College
Hospital,  Chennai,  Tamil   Nadu,  India  during  the  study  period  of  six
months from April 2017 to September 2017 were included in this study.
Among them 34 neonates were delivered by normal vaginal delivery and
caesarean section each and 2 by forceps delivery.
Table.1
Descriptive analysis of MODE OF DELIVERY in study population
(N=70)
MODE OF DELIVERY Number Percentages
FORCEPS 2 2.86%
LSCS 34 48.57%
NVD 34 48.57%
The proportion of FORCEPS was 2.86%, and LSCS, NVD
respectively 48.57% in the study population. (Table 1& fig 1)
Figure.1
Pie chart of MODE OF DELIVERY distribution in study population
(N=70)
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Table.2
Descriptive analysis of IM/EM in study population (N=70)
IM/EM Number Percentage
Intramural 58 82.86%
Extramural 12 17.14%
Among the study population, the number of babies born within the
institution was 58 (82.86%) and the number referred from outside was 12
(17.14%). (Table2, fig 2)
Figure.2
Bar chart of IM/EM distribution in study population (N=70)
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Table.3
Descriptive analysis of Gender in study population (N=70)
Gender Number Percentage
Male 39 55.71%
Female 31 44.29%
Among the study population, the Male were 39 (55.71%) and
female were 31 (44.29%).  (Table 3, fig 3)
Figure.3
Bar chart of Gender distribution in study population (N=70)
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Table.4
Descriptive analysis of TERM/PRE TERM/POST TERM in study
population (N=70)
TERM/PRE
TERM/POST TERM Number Percentage
Preterm 19 27.14%
Term 51 72.86
Post term 0 0%
Among the study population, the Preterm were 19 (27.14%) and
term were 51 (72.86%) and there were no preterm  (Table 4, fig 4)
Figure.4
Pie chart of TERM/PRE TERM/POST TERM distribution in study
population (N=70)
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Table.5
Descriptive analysis of AGA/SGA/LGA in study population (N=70)
AGA/SGA/LGA Number Percentages
SGA 19 27.14%
AGA 49 70.00%
LGA 2 2.86%
Among the study population, the SGA was 19 (27.14%), AGA, and
LGA was 49 (70.00%), and 2 (2.86%) respectively. (Table 5, fig 5)
Figure.5
Pie chart of AGA/SGA/LGA distribution in study population (N=70)
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Table.6
Descriptive analysis for Birth weight in study population (N=70)
Parameter Mean±STD Median Min Max
95% C.I. for EXP(B)
Lower Upper
Birth
weight
2.56 ± 0.67 2.53 0.99 4.16 2.40 2.72
The mean birth weight of study population was 2.56 with minimum
0.99 kg and maximum 4.16 kg. (95% CI 2.40 to 2.72). (Table 6)
Table.7
Descriptive analysis of Birth weight category in study population
(N=70)
Birth weight cat (kg) Number Percentage
Low birth weight (<2.5kg) 31 44.29%
Normal Birth weight (?2.5kg) 39 55.71%
Among the study population, babies with Low birth weight
(<2.5kg) were 31 (44.29%), and with Normal Birth weight (?2.5kg) were
39 (55.71%). (Table 7, fig6)
Figure.6
Pie chart of Birth weight category distribution in study population
(N=70)
Table.8
Descriptive analysis for DAY OF ONSET OF SEIZURES in study
population (N=70)
Parameter Mean ±STD Median Min Max
95% C.I. for EXP(B)
Lower Upper
DAY OF
ONSET OF
SEIZURES
3.26 ± 3.06 2.00 1.00 17.00 2.53 3.99
The mean day of  onset  of  seizures was 3.26 with minimum 1 and
maximum 17 in the study population. (95% CI 2.40 to 2.72). (Table 8)
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Table.9
Descriptive analysis of Day of Onset Category in study population
(N=70)
Day of onset category Number Percentage
Within 24 hours 20 28.57%
24 to 72 Hours (day 1 to 3) 31 44.29%
4th day to 1 week (day 4 to 7) 14 20.00%
More than 1 week (More than
7 days) 5 7.14%
In our study onset of seizures  within 24 hours was 20 (28.57%), 24
to 72 Hours (day 1 to 3), 4th day to 1 week (day 4 to 7), and More than 1
week (More than 7 days) was 31 (44.29%), 14 (20.00%) and 5 (7.14%)
respectively. Convulsions in the first 3 days contributes to 72.86% (Table
9, fig 7)
Figure.7
Bar chart of Day of onset category distribution in study population
(N=70)
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Table.10
Descriptive analysis of Type of Seizures in study population (N=70)
TYPE OF
SEIZURES Number Percentages
Subtle 43 61.43%
Tonic 18 25.71%
Clonic 9 12.86%
Among the study population, number of neonates with subtle
seizures were 43 (61.43%), Tonic and Clonic were 18 (25.71%) and 9
(12.86%) respectively. (Table 10, fig 8)
Figure.8
Bar chart of Type of Seizures distribution in study population (N=70)
61.43%
25.71%
12.86%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
Subtle Tonic Clonic
Pe
rc
en
ta
ge
s
TYPE OF SEIZURES
Table.11
Descriptive analysis of HYPO GLYCEMIA in study population
(N=70)
HYPO
GLYCEMIA Number Percentage
Yes 17 24.29%
No 53 75.71%
Out of 70 subjects in my study, 17(24.29%) subjects were reported
to have hypoglycemia. (Table 11, fig 9)
Figure.9
Pie chart of HYPO GLYCEMIA distribution in study population
(N=70)
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Table.12
Descriptive analysis of HYOCALCEMIA in study population (N=70)
HYOCALCEMIA Number Percentage
Yes 14 20.00%
No 56 80.00%
Out of 70 neonates, 14(20.00%) neonates had hyocalcemia in my
study (Table 12, fig 10)
Figure.10
Pie chart of HYPOCALCEMIA  distribution in study population
(N=70)
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Table.13
Descriptive analysis of HYPONATREMIA in study population
(N=70)
HYPONATREMIA Number Percentage
Yes 6 8.57%
No 64 91.43%
Out of 70 subjects, hyponatremia were reported in 6 neonates
(8.57%). (Table 13, fig 11)
Figure.11
Pie chart of HYPONATREMIA distribution in study population
(N=70)
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Table.14
Descriptive analysis of HYPOMAGNESEMIA in study population
(N=70)
HYPO
MAGNESEMIA Number Percentage
Yes 3 4.29%
No 67 95.71%
Out of 70 neonates, 3(4.29%) neonates had hypomagnesemia.
(Table 14, fig 12)
Figure.12
Pie chart of HYPO MAGNESEMIA distribution in study population
(N=70)
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Table.15
Descriptive analysis of hypernatremia in study population (N=70)
HYPERNATREMIA Number Percentage
Yes 3 4.29%
No 67 95.71%
In my study hypernatremia were observed in 3 (4.29%) neonates
out of 70.(Table 15, fig 13)
Figure.13
Pie chart of hypernatremia distribution in study population (N=70)
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Table.16
Summary of various biochemical abnormalities in study population
Various Biochemical
Abnormalities
Number
N=70
Percentage
HYPO GLYCEMIA 17 24.29%
HYPOCALCEMIA 14 20.00%
HYPO NATREMIA 6 8.57%
HYPO MAGNESIMIA 3 4.29%
HYPERNATREMIA 3 4.29%
Note: The total percentages may not match 100% as this table reported
the frequency of various metabolic abnormality which are not mutually
exclusive.
Figure.14
Bar chart of summary of various biochemical abnormalities in study
population
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Table.17
Descriptive analysis of combine hypoglycemia and hypocalcemia in
study population (N=70)
Combine
HYPOGLYCEMIA AND
HYPOCALCEMIA
Frequency Percentage
Yes 2 2.86%
No 68 97.14%
Out of 70 subjects, 2(2.86%) neonates were reported to had
combine hypoglycemia and hypocalcemia.(Table 17, fig 15)
Figure.15
Bar chart of combine hypoglycemia and hypocalcemia in study
population (N=70)
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Table.18
Descriptive analysis of COMBINATION OF HYPOCALCEMIA
AND HYPOMAGNESEMIA in study population (N=70)
Combination Of Hypocalcemia
And Hypomagnesemia Frequency Percentage
yes 1 1.43%
No 69 98.57%
Out of 70 subjects 1(1.43%) subjects were reported to have
combine hypocalcemia and hypomagnesemia.(Table 18, fig 16)
Figure.16
Bar chart of combination of hypocalcemia and hypomagnesemia
distribution in study population (N=70)
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Table.19
Association of TERM/PRE TERM with HYPO GLYCEMIA of study
population (N=70)
HYPOGLYCEMIA
TERM/PRETERM
Chi
square
P-
valuePreterm
(N=19)
Term
(N=51)
Yes 7 (36.84%) 10 (19.61%)
2.236 0.135
No 12 (63.16%) 41 (80.39%)
Among 19 preterm babies 7 (36.84%) had hypoglycemia, among
51 term babies only 10 (19.61%) had hypoglycemia. The difference in
proportion of hypoglycemia between term and preterm babies was
statistically not significant (P value 0.135) (Table 19& fig 17)
Figure.17
Clustered bar chart of Association of TERM/PRE TERM with
HYPO GLYCEMIA of study population (N=70)
Table.20
Association of TERM/PRE TERM with Hypocalcaemia of study
population (N=70)
HYPOCALCEMIA
TERM/PRETERM Chi
square
P-
valuePre term (N=19) Term (N=51)
Yes 6 (31.58%) 8 (15.69%)
2.185 0.139
No 13 (68.42%) 43 (84.31%)
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Among 19 preterm babies 6 (31.58%)had hypocalcemia, among 51
term babies only 8 (15.69%)had hypocalcemia. The difference in
proportion of hypocalcemia between term and preterm babies was
statistically not significant (P value 0.139) (Table 20 & fig 18)
Figure.18
Clustered bar chart of Association of TERM/PRE TERM with
Hypocalcaemia of study population (N=70)
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Table.21
Association of TERM/PRE TERM with HYPO NATREMIA of study
population (N=70)
HYPO
NATREMIA
TERM/PRE TERM
Chi
square
P-
valuePre term
(N=19) Term (N=51)
Yes 2 (10.53%) 4 (7.84%)
0.127 0.721
No 17 (89.47%) 47 (92.16%)
Among 19 preterm babies 2 (10.53%) had hyponatremia, among 51
term babies only 4 (7.84%) had hyponatremia. The difference in
proportion of hyponatremia between term and preterm babies was
statistically not significant (P value 0.721) (Table 21 & fig 19)
Figure.19
Clustered bar chart of Association of TERM/PRE TERM with
HYPO NATREMIA of study population (N=70)
Table.22
Association of TERM/PRE TERM with HYPO MAGNESEMIA of
study population (N=70)
HYPOMAGNESEMIA
TERM/PRETERM
Chi
square P-valuePre term
(N=19) Term (N=51)
Yes 2 (10.53%) 1 (1.96%)
2.476 0.116
No 17 (89.47%) 50 (98.04%)
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Among 19 preterm babies 2 (10.53%) had hypomagnesemia,
among 51 term babies only 1 (1.96%)had hypomagnesemia. The
difference in proportion of hypomagnesemia between term and preterm
babies was statistically not significant (P value 0.116) (Table 22& fig 20)
Figure.20
 Clustered bar chart of association of term/pre term with
hypomagnesemia of study population (N=70)
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Table.23
Association of TERM/PRETERM with HYPERNATREMIA of study
population (N=70)
HYPERNATREMIA
TERM/PRE TERM
Pre term (N=19) Term (N=51)
Yes 0 (0%) 3 (5.88%)
No 19 (100%) 48 (94.12%)
Among 51 term babies only 3 (5.88%) had hypernatremia.
Hypernatremia were not reported in preterm babies in my study. (Table
23& fig 21)
Figure.21
Clustered bar chart of association of term/pre term with
hypernatremia of study population (N=70)
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Table.24
Association of TERM/PRETERM/POSTTERM with Combine
HYPOGLYCEMIA AND HYPOCALCEMIA of study population
(N=70)
Combine
HYPOGLYCEMIA AND
HYPOCALCEMIA
TERM/PRETERM
Pre term (N=19) Term (N=51)
Yes 2 (10.53%) 0 (0%)
No 17 (89.47%) 51 (100%)
Among 19 preterm babies only 2 (10.53%)had combine
hypoglycemia and hypocalcemia. This combination was not reported in
term babies (Table 24& fig 22)
Figure.22
Clustered bar chart of association of term/pre term with combine of
hypo glycaemia and hypocalcemia of study population (N=70)
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Table.25
Association of TERM/PRETERM/POSTTERM with
COMBINATION OF HYPOCALCEMIA AND
HYPOMAGNESEMIA of study population (N=70)
COMBINATION OF
HYPOCALCEMIA
AND
HYPOMAGNESEMIA
TERM/PRETERM/POSTTERM
Pre term (N=19) Term (N=51)
Yes 1 (5.26%) 0 (0%)
No 18 (94.74%) 51 (100%)
Among 19 preterm babies only 1(5.26%)neonate had combination
of hypocalcemia and hypomagnesemia. (Table 25& fig 23)
Figure.23
Clustered bar chart of Association of Term/Pre Term with Type of
Seizures of study population (N=70)
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Table.26
Association of Term/PreTerm with AGA/SGA/LGA of study
population (N= 70)
AGA/SGA/LGA TERM/PRE TERM/POST TERM
Pre term (N=19) Term (N=51)
SGA 5 (26.32%) 14 (27.45%)
AGA 14 (73.68%) 35 (68.63%)
LGA 0 (0%) 2 (3.92%)
Among 19 preterm babies 5 (26.32%) were SGA, and 14 (73.68%)
were AGA. Among 51 term babies 14 (27.45%) were SGA, 35 (68.63%)
were AGA, and only 2 (3.92%) were LGA. (Table 26& fig 24)
Figure.24
Clustered bar chart of Association of TERM/PRE TERM with
AGA/SGA/LGA of study population (N= 70)
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Table.27
Association of Term/Pre Term with Type of Seizures of study
population (N=70)
TYPE OF
SEIZURES
TERM/PRE TERM/POST
TERM Chi
square
P-
value
Pre term (N=19) Term (N=51)
subtle 12 (63.16%) 31 (60.78%)
0.407 0.816tonic 4 (21.05%) 14 (27.45%)
Clonic 3 (15.79%) 6 (11.76%)
Among 19 preterm babies, 12 (63.16%) had subtle seizures
,4(21.05%) had tonic, and 3 (15.79%) had clonic type of seizures. Among
51 term babies, 31(60.78%) had subtle, 14 (27.45% ) had tonic, and 6
(11.76%) had clonic seizures .The difference in proportion of type of
seizures between term and preterm babies was statistically not significant
(P value 0.116). (Table 27& fig 25)
Figure.25
Clustered bar chart of Association of Term/Pre Term with Type of
Seizures of study population (N=70)
In my study subtle seizures observed in preterm babies were
63.16% compared to 60.78% in term neonates. Likewise tonic seizures
occurred in 21.05% of preterm compared to 27.45% in term. Clonic
seizures contributes about 15.79% in preterm and 11.76% in term.
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DISCUSSION
Seizures are most common neurological disorders in newborn
which are more prevalent in preterm neonates compared to term neonates.
In my study, a total of 70 neonates with seizures who got admitted into
the neonatal intensive care unit of government kilpauk medical college
satisfying the inclusion and exclusion criteria were included.
Gestational age
Out of 70 neonates, full term neonates were 51 (72.86 %) and
preterm constitutes 19 in number (27.14%).there were no post term
babies in my study. Among 70 neonates, 49 were appropriate for
gestational age, 19 were small for gestational age, 2 were large for
gestational age constituiting about 70%, 27.14%, 2.86% respectively.
Majority of neonates with seizures in my study were full term appropriate
for gestational age neonates. Similar observations were seen in study by
Aziz  et  al(12)where term babies constitutes 65% and preterm 35% and
AGA 68%, SGA 26% and LGA 6%. In studies by Park Weon et al (22)
and Dinesh Das et  al (83), they also reported a much higher incidence in
term babies compared to preterm neonates. Dinesh das et al(83) observed
seizures in 91.3% of term, 7.8% in preterm and 0.9 % in posterm.
Sex of the neonate
 In my study neonatal seizures were common in male babies
contributing about 55.71% and female neonates contributes about
44.29%, with a male:female ratio of about 1.25:1. Studies by Aziz et  al
(12) (male 60%,female 40%) and Dinesh Das et al (83) (male 62.6%, female
37.4% ) also reported male predominance. In yet another study by
Tekgul et al (52) showed male:female ratio to be  1.15:1 whereas Sudia et
al (84) reported 1.73:1further supporting my study that seizures are
common in males.
Type of delivery
In my study, 34 babies (48.57%) born by normal vaginal delivery,
34 babies (48.57%) by caeserian section and 2 babies by forceps delivery
(2.86%). Aziz et  al(12) in his study reported neonates with seizures born
by normal vaginal delivery in 48%, by lower segment caeserian section in
28% and operated vaginal in 24%.
Birth weight
 In my study 39 neonates (55.71%) had birth weight >2.5kg and 31
neonates (44.29%) had birth weight < 2.5 kg .similar observations were
made by Dinesh Das et al(83) where neonates >2.5 kg were 65% and
<2.5kg were 35% respectively.
Day of onset of seizures
 In my study out of 70 neonates, 20 had seizures within 24 hours
(28.57%) , 31 neonates between 24-72 hours (44.29%) , 14 babies
between day 4 to 7 (20%)  and 5 babies above 7 days (7.14%). Thus most
of the seizures occurred within the first 3 days of life contributing about
72.86% of neonates in my study. Similar observations were made by
Dinesh  Das  et  al(83) where seizures within 3 days was reported to be
71.3% and Nawab et al(82) observed 73.6 % of neonatal seizures within 3
days which were comparable with my study.
Type of seizures
We found in our study that subtle seizures were the most common
type of neonatal seizures contributing to about 61.43% in about 43
neonates , followed by tonic seizures in 25.7% and clonic seizures in
about 12.86% of neonates. Similar findings were reported by Sudia et al
where subtle seizures occurred in 63.33% followed by generalized tonic
in 19.33% and multifocal clonic in 10% of neonates. Dinesh das et al(83)
in his studies on neonatal seizures also observed subtle seizures to be the
most commonest type contributing about 42.6% followed by tonic in
33.9% and clonic in 15.7% of neonates. Various studies by Yadav et al
(11), Park Weon et al (22) and Nawab et al (82) also reported subtle seizures
to  be  the  most  common  type  observed  in  their  studies  which  were
comparable with my study.
Overall biochemical abnormality
In my study, out of 70 neonates, 34 babies with seizures had one or
more biochemical abnormalities contributing to about 48.57% in total.
Sood et al(39) in his study has observed an overall biochemical
abnormalities in 29 cases constituting of about 49.15 % which was
comparable with my study. Similar observations were made by Nawab et
al (82) in his studies where out of 110 neonates, 46 babies had biochemical
abnormalities contributing about 41.8% cases in total. Kumar et al (81)
has found overall biochemical abnormalities in 62.8% of neonates against
Madhusudan et al’s(80) 43.33%
Comparison of overall metabolic abnormalities as reported by
various authors:
 OVERALL BIO-
CHEMICAL
ABNORMALITY
KUMAR
1995
N=35
ARAVIND
SOOD
1997
N=59
MADHU-
SUDAN
2016
N=120
PRESENT
STUDY
N=70
PRESENT 22 (62.8%) 29 (49.15%) 52 (43.33%) 34 (48.57%)
ABSENT 13 (37.2%) 30 (50.85%) 68 (56.66%) 36 (51.42%)
TOTAL 35 (100%) 59 (100%) 120 (100%) 70 (100%)
In my study among babies with metabolic disturbances,
Hypoglycemia was noted in 17 babies contributing to about 50%,
followed by hypocalcemia in 14 neonates (41.17%) , hyponatremia in 6
neonates (17.64%), hypomagnesemia in 3 neonates (8.8%) and
hypernatremia in 3 neonates (8.8%). There were also 2 cases reported
with combination of hypoglycemia and hypocalcemia and one case with
hypocalcemia and hypomagnesemia in my study occurring especially in
preterm neonates. In a study by Sood  et  al 39) on 59 neonates,
hypoglycemia was found in 48.27%, hypocalcemia in
48.27%,hyponatremia in 17.25%, hypomagnesemia in 17.24% which
were comparable with my study. Kumar et al (81) in his study has reported
the incidence of hyponatremia to be 45.5%,hypoglycemia 50%,
hypocalcemia 31.8%, hypomagnesemia in 13.63% of cases.He also
reported hypermagnesemia in 4.54% and hyperphosphatemia in 13.63%
of cases. A comparative study by Kumar et al and Sood et al with my
study has been discussed below.
Comparison of most common biochemical abnormalities in neonatal
seizures as reported by various authors :
BIOCHEMICAL
PARAMETER
KUMAR
1995
N=35
ARAVIND
SOOD 1997
N=59
PRESENT
STUDY
N=70
Hypoglycemia 11 (50%) 14 (48.27%) 17 (50%)
Hypocalcemia 7 (31.8) 14 (48.27%) 14 (41.17%)
Hyponatremia 10 (45.5%) 5 (17.25%) 6 (17.64%)
Hypomagnesemia 1 (13.63%) 5 (17.24%) 3 (8.8%)
Hypernatremia 0 0 3 (8.8%)
Hypo ca+ hypo mg 0 0 1 (2.94%)
Hypermagnesimia 1 (4.54%) 0 0
Hyperphosphatemia 3 (13.63%) 0 0
Hypoglycemia+ hypo ca 0 0 2(5.88%)
Order of biochemical abnormalities
 The most common biochemical abnormality reported in my study
were hypoglycemia followed hypocalcemia particularly in preterm
neonates. Among preterm babies the incidence of hypoglycemia were
36.84% compared to 19.61% in term babies . Hypocalcemia was reported
in 31.58% among preterm babies which was higher when compared with
term babies of about 15.69%. Suganthi et al(77) in her study has made
similar observations where Metabolic abnormalities were present in 89
(59.3%) out of 150 cases. Of these, hypoglycemia and hypocalcemia
were the most common with 39 (43.8%) and 28 (35.4%) cases
respectively. Sameer kumar jain et al(79), shah et al (85)and Iype maya
Prasad et al (19) also found hypoglycemia followed by hypocalcemia to
be most common metabolic disturbances in their study further supporting
my findings. Whereas Yadav et al (11) and Sarkar et al (86) has found
hypocalcemia followed by hypoglycemia to be the commonest
biochemical abnormalities in their study. Further Dinesh Das et al (40) in
his study has added that hypoglycemia was more prevalent among
preterm neonates as suggested by my study. Thus all these studies suggest
the importance of doing biochemical work up in neonatal seizures
especially blood glucose and calcium levels which are more prevalent and
correction of these transient biochemical abnormalities is associated with
good prognosis and outcome.
In  my  study  2  cases  had  been  reported  with  combination  of
hypoglycemia and hypocalcemia (5.88%) and one case with
hypocalcemia and hypomagnesemia (2.94%) in my study occurring
especially in preterm neonates. Sudia et al(78 in her study had reported
hypoglycemia and hypocalcemia combination in 9% and hypocalcemia
hypomagnesemia combination in 7.9% cases. Nawab et al(82) also
described occurance of similar combinations in his study.
SUMMARY
1.  In my study, neonatal seizures occured more commonly in term
babies (72.86%) especially in appropriate for gestational age babies
compared to preterm neonates.
2.  There was a male predominance (55.71%) of neonatal seizures and
there is no significant difference between the mode of delivery.
3.  Most of the seizures occurred in hospital deliveries (82.86%).
4.  More percentage of neonatal seizures have been noted in babies
with birth weight >2.5kg (55.71%).
5.  Most neonatal seizures occurred during the first 3 days of life
(72.86%)
6.  The most common type of seizures observed was subtle seizures
(61.43) followed by tonic and clonic.
7.  The most common biochemical abnormality noted in my study was
hypoglycemia (50%) and hypocalcemia (41.17).
8. There were cases reported with combination of
hypocalcemia/hypomagnesemia and hypoglycemia/hypocalcemia
particularly in preterm neonates but their incidence is low.
LIMITATIONS
1. In our study, we have identified neonatal seizures based on clinical
criteria alone. In our setup where continuous video EEG
monitoring is not available, which is necessary for confirming
abnormal electroencephalogram discharge, there may be chances
that we could have missed the electrographic seizures, so that the
real magnitude of neonatal seizures is not known. Moreover there
may be overdiagnosis or underdiagnosis of cases based on inter-
observer variation and lack of continuous in-function cerebral
monitor.
2. The duration of study was only 6 months. There is still a need for
research with large sample size and longer duration to find out the
association between various biochemical abnormalities in a
conclusive manner. Moreover the etiology of the neonatal seizures
is not discussed which could be vital in determining the associated
metabolic abnormalities and also in predicting the prognosis and
long term outcome of neonatal seizures which depends upon its
cause.
CONCLUSION
Neonatal seizures are one of the most common neurological
problems in neonates. There are various causes for neonatal seizures,
which not only determines the course of the disease but also helps in
determining its associated long term neurological outcome along with
mortality and morbidity. Quick assessment, timely diagnosis and
aggressive management according to the etiology are necessary to
prevent these problems. Moreover biochemical abnormalities may either
occur as a primary problem or may be associated with other etiologies.
These transient abnormalities are easily treatable when identified
early and are associated with good prognosis. Hence biochemical work
up should be done in all neonates with seizures and should be included as
the first line of investigations in all cases. Early correction of these
biochemical abnormalities help in preventing the further occurrence of
seizures and also helps in avoiding over use of anticonvulsants which
may be unnecessary in some cases. Further early correction of these
metabolic disturbances improve the prognosis and outcome of the
neonate and also prevent the long term neurological sequelae associated
with it.
Wherever possible continuous video EEG monitoring should be
included in identifying the neonatal seizures to know the real magnitude
of the problem and to treat these seizures promptly.
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B/O SANDHYA KAVIARASAN LSCS 0 1 1 0 1.92 0 2 0 0 0 0 0
B/O POORNI ARUN LSCS 0 1 1 0 2.38 0 3 0 0 0 1 0
B/O BAEULA RAJAKUMARI LSCS 0 1 1 1 2.61 2 1 0 0 1 0 0
0 =
intramural 0 = male 0= preterm sga = 0 subtle = 0 YES-1 YES-1 YES-1 YES-1 YES-1
1=
extramural
1 =
female 1= term aga = 1 tonic = 1 NO-0 NO-0 NO-0 NO-0 NO-0
2 = post term lga = 2 clonic =2
myoclonic = 3
